Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Helius Medical Technologies Inc (HSM.TO)

Helius Medical Technologies Inc (HSM.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 42,531
  • Shares Outstanding, K 2,318
  • Annual Sales, $ 644 K
  • Annual Income, $ -8,850 K
  • 60-Month Beta 1.09
  • Price/Sales 53.86
  • Price/Cash Flow N/A
  • Price/Book 4.02
Trade HSM.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -8.24
  • Most Recent Earnings $-2.58 on 08/12/21
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -2.20
  • Number of Estimates 1
  • High Estimate -2.20
  • Low Estimate -2.20
  • Prior Year -3.85
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.83 +15.92%
on 08/17/21
19.68 -6.76%
on 08/10/21
-1.52 (-7.65%)
since 08/09/21
3-Month
15.83 +15.92%
on 08/17/21
21.17 -13.32%
on 06/25/21
+0.88 (+5.04%)
since 06/09/21
52-Week
14.26 +28.68%
on 01/04/21
40.00 -54.13%
on 01/05/21
-1.25 (-6.38%)
since 09/09/20

Most Recent Stories

More News
Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022

NEWTOWN, Pa., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech...

HSDT : 4.98 (-1.87%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. to Release First Quarter 2022 Financial Results on May 12, 2022

NEWTOWN, Pa., May 03, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech...

HSDT : 4.98 (-1.87%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. to Present at the Benzinga Healthcare Small Cap Conference

NEWTOWN, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...

HSM.TO : 18.35 (-1.71%)
HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.98 (-1.87%)
Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors

NEWTOWN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced...

HSM.TO : 18.35 (-1.71%)
HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.98 (-1.87%)
LIVN : 55.02 (+1.87%)
Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

NEWTOWN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.98 (-1.87%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange

NEWTOWN, Pa., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.98 (-1.87%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke

NEWTOWN, Pa., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.98 (-1.87%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Reports Second Quarter 2021 Financial Results

NEWTOWN, Pa., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.98 (-1.87%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness,...

HSDT : 4.98 (-1.87%)
HSM.TO : 18.35 (-1.71%)
HSM-S.TO : 1.98 (-1.49%)
Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians

NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...

HSM-S.TO : 1.98 (-1.49%)
HSDT : 4.98 (-1.87%)
HSM.TO : 18.35 (-1.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator...

See More

Key Turning Points

3rd Resistance Point 18.57
2nd Resistance Point 18.52
1st Resistance Point 18.44
Last Price 18.35
1st Support Level 18.31
2nd Support Level 18.26
3rd Support Level 18.18

See More

52-Week High 40.00
Fibonacci 61.8% 30.17
Fibonacci 50% 27.13
Fibonacci 38.2% 24.09
Last Price 18.35
52-Week Low 14.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar